|
CSE1L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.573600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.614300E-02 |
| Normal-vs-Stage2 |
1.037230E-01 |
| Normal-vs-Stage3 |
1.173590E-01 |
| Normal-vs-Stage4 |
2.367600E-01 |
| Stage1-vs-Stage2 |
5.819000E-01 |
| Stage1-vs-Stage3 |
8.766600E-01 |
| Stage1-vs-Stage4 |
7.592800E-01 |
| Stage2-vs-Stage3 |
7.104400E-01 |
| Stage2-vs-Stage4 |
5.083400E-01 |
| Stage3-vs-Stage4 |
7.048400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.286630E-01 |
| Normal-vs-AfricanAmerican |
8.690400E-01 |
| Normal-vs-Asian |
5.147700E-02 |
| Caucasian-vs-AfricanAmerican |
3.810000E-01 |
| Caucasian-vs-Asian |
4.467800E-01 |
| AfricanAmerican-vs-Asian |
2.557400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.437900E-02 |
| Normal-vs-Female |
1.094580E-01 |
| Male-vs-Female |
7.036000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.988610E-01 |
| Normal-vs-Age(41-60Yrs) |
3.103500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.872400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.347220E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.683000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.231200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.922200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.318800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.188600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.490600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.070800E-01 |
| Classical-VS-Follicular |
8.90399999953218E-07 |
| Classical-VS-Other |
1.769570E-01 |
| Classical-VS-Normal |
4.730200E-01 |
| Tall-VS-Follicular |
4.950000E-04 |
| Tall-VS-Other |
9.050000E-02 |
| Tall-VS-Normal |
9.335800E-01 |
| Follicular-VS-Other |
8.009000E-01 |
| Follicular-VS-Normal |
4.38890000000747E-05 |
| Other-VS-Normal |
8.188300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.130150E-02 |
| Normal-vs-N1 |
8.424300E-03 |
| N0-vs-N1 |
4.555000E-01 |
|
|
